Iradimed Co Stock Today
| IRMD Stock | USD 53.93 0.35 0.65% |
Performance10 of 100
| Odds Of DistressLess than 5
|
Iradimed is trading at 53.93 as of the 30th of November 2024, a 0.65% increase since the beginning of the trading day. The stock's lowest day price was 53.52. Iradimed has under 5 % chance of experiencing financial distress over the next 2 years and had a ok performance during the last 90 days. Equity ratings for Iradimed Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 16th of July 2014 | Category Healthcare | Classification Health Care |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devices, and related accessories and services in the United States and internationally. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. The company has 12.67 M outstanding shares of which 85.85 K shares are currently shorted by private and institutional investors with about 2.49 trading days to cover. More on Iradimed Co
Moving together with Iradimed Stock
Moving against Iradimed Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Iradimed Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Roger Susi | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIradimed can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Iradimed's financial leverage. It provides some insight into what part of Iradimed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Iradimed Co (IRMD) is traded on NASDAQ Exchange in USA. It is located in 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708 and employs 148 people. Iradimed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 683.48 M. Iradimed conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 12.67 M outstanding shares of which 85.85 K shares are currently shorted by private and institutional investors with about 2.49 trading days to cover.
Iradimed Co currently holds about 55.59 M in cash with 13.47 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.42.
Check Iradimed Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Iradimed is $683.48 Million. Over half of Iradimed's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Iradimed Ownership Details
Iradimed Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Acadian Asset Management Llc | 2024-06-30 | 160.4 K | |
| Northern Trust Corp | 2024-09-30 | 133.3 K | |
| Hightower Advisors, Llc | 2024-06-30 | 103 K | |
| Soleus Capital Management, L.p. | 2024-06-30 | 102.1 K | |
| Millennium Management Llc | 2024-06-30 | 83.1 K | |
| Goldman Sachs Group Inc | 2024-06-30 | 79 K | |
| Rice Hall James & Associates, Llc | 2024-09-30 | 71.6 K | |
| Teacher Retirement System Of Texas | 2024-09-30 | 70.1 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 66.6 K | |
| Nine Ten Capital Management Llc | 2024-09-30 | 905.9 K | |
| Blackrock Inc | 2024-06-30 | 818.3 K |
Iradimed Historical Income Statement
Iradimed Stock Against Markets
Iradimed Corporate Management
| Randy Waddell | Vice Marketing | Profile | |
| Lynn Neuhardt | Vice Development | Profile | |
| Chris Williamson | Executive Technology | Profile | |
| Matt Garner | Controller | Profile | |
| Steve Kachelmeyer | Vice Assurance | Profile | |
| John Glenn | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0) | Dividend Share 0.45 | Earnings Share 1.46 | Revenue Per Share 5.635 | Quarterly Revenue Growth 0.11 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.